RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY

被引：0

作者：

Goy, A. ^{[1
]}

Offner, F. ^{[2
]}

Martinelli, G. ^{[3
]}

Caballero, D. ^{[4
]}

Gadeberg, O. ^{[5
]}

Gaidano, G. ^{[6
]}

Press, O. ^{[7
]}

Fine, G. ^{[8
]}

Chai, A. ^{[8
]}

Sahin, D. ^{[9
]}

Sehn, L. ^{[10
]}

机构：

[1] John Theurer Canc Ctr, Hackensack, NJ USA

[2] Univ Ghent, Ghent, Belgium

[3] Univ Bologna, S Orsola Malpighi Hosp, Bologna, Italy

[4] Hosp Clin Univ, Salamanca, Spain

[5] Vejle Hosp, Vejle, Denmark

[6] Amedeo Avogadro Univ Eastern Piedmont, Novara, Italy

[7] Univ Washington, Seattle, WA 98195 USA

[8] Genentech BioOncol, San Francisco, CA USA

[9] Kocaeli Univ, Kocaeli, Turkey

[10] BC Canc Agcy, Vancouver, BC, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0790

引用

页码：322 / 323

页数：2